Integrated BioPharma, Inc. (INBP)

Integrated BioPharma Revenue

In the fiscal year ending June 30, 2024, Integrated BioPharma had annual revenue of $50.32M, down -0.70%. Integrated BioPharma had revenue of $12.75M in the quarter ending June 30, 2024, a decrease of -1.91%.

• Revenue: 50.32M
• Revenue Growth: -0.70%
• P/S Ratio: 0.15
• Revenue / Employee: 342.29K
• Employees: 141
• Market Cap: 7.52M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	50.32M	-355.00K	-0.70%
Jun 30, 2023	50.67M	-5.57M	-9.91%
Jun 30, 2022	56.25M	-7.31M	-11.51%
Jun 30, 2021	63.56M	10.79M	20.45%
Jun 30, 2020	52.77M	2.79M	5.59%